| 1 |
35108047 | Injectable hydrogel microspheres with self-renewable hydration layers alleviate osteoarthritis. | 2022 Feb 4 |
1 |
| 2 |
35286973 | The GLUT1-mTORC1 axis affects odontogenic differentiation of human dental pulp stem cells. | 2022 Jun |
1 |
| 3 |
35422798 | Therapeutic Effect of Rapamycin-Loaded Small Extracellular Vesicles Derived from Mesenchymal Stem Cells on Experimental Autoimmune Uveitis. | 2022 |
1 |
| 4 |
33141044 | Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer. | 2021 Jan 1 |
1 |
| 5 |
33225417 | Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy. | 2021 Feb |
1 |
| 6 |
33795781 | Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery. | 2021 Apr 1 |
1 |
| 7 |
31698038 | Inhaled rapamycin solid lipid nano particles for the treatment of Lymphangioleiomyomatosis. | 2020 Jan 15 |
1 |
| 8 |
32548088 | Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease. | 2020 |
1 |
| 9 |
32812483 | Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part II: the effect of nanoparticle charge. | 2020 Aug |
1 |
| 10 |
32820673 | Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size. | 2020 Aug |
2 |
| 11 |
30935290 | Microfluidic preparation of PLGA microspheres as cell carriers with sustainable Rapa release. | 2019 May - Jun |
2 |
| 12 |
28535645 | [Effect of rapamycin and chloroquine on osteosarcoma]. | 2017 May 23 |
3 |
| 13 |
27338360 | Role of mTOR Inhibitors in Kidney Disease. | 2016 Jun 21 |
2 |
| 14 |
26071480 | High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses. | 2015 Oct 1 |
2 |
| 15 |
26375670 | Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients. | 2015 Oct 6 |
1 |
| 16 |
23369601 | Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation. | 2012 Sep 28 |
1 |
| 17 |
19805415 | Rapamycin: the cure for all that ails. | 2010 Feb |
1 |
| 18 |
18308998 | Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. | 2008 Mar |
1 |
| 19 |
17645419 | Calcineurin inhibitor-free immunosuppression in kidney transplantation. | 2007 Oct |
1 |
| 20 |
17660033 | Monitoring biological action of rapamycin in renal transplantation. | 2007 Aug |
1 |
| 21 |
16298655 | Metabolic effect of sirolimus versus mycophenolate mofetil on pancreatic graft function in the early posttransplant period. | 2005 Oct |
1 |
| 22 |
15307840 | CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. | 2004 Sep |
1 |
| 23 |
15760093 | Exposure-response relationships and drug interactions of sirolimus. | 2004 Oct 15 |
1 |
| 24 |
12742487 | Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients. | 2003 May |
1 |
| 25 |
12177161 | Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. | 2002 Aug |
1 |
| 26 |
11602850 | Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients. | 2001 Oct 15 |
1 |
| 27 |
9029760 | Determination of rapamycin in whole blood by HPLC. | 1997 Feb |
1 |
| 28 |
9399022 | Radioreceptor assay for sirolimus in patients with decreased platelet counts. | 1997 Oct |
1 |
| 29 |
8770969 | The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients. | 1996 Jan |
1 |
| 30 |
8884067 | Radioreceptor assay for sirolimus. | 1996 Oct |
1 |